Future Science Group

Future Science Group is a scientific and medical publishing group associated with a portfolio of research-focused journals and related publishing activities. The group operates in scholarly communication, serving researchers, clinicians, professional societies, and other participants in the life-sciences and healthcare communities. Its publishing activities include subscription and open-access models, with individual journals operating under different arrangements according to the needs of their readerships and society partners. A documented part of the group is Future Medicine, a London-based publishing company focused primarily on peer-reviewed medical journals. Future Medicine has published both hybrid journals, which combine subscription access with open-access options, and fully open-access journals. In the open-access model, authors or their funders generally pay article-processing charges to support publication and access. The company has also offered an accelerated publication route intended to process and publish accepted manuscripts within approximately six weeks of submission, subject to editorial and peer-review decisions. The group's portfolio has included titles spanning clinical medicine, translational research, diagnostics, therapeutics, and related biomedical fields. Its journals have served specialist communities rather than a general consumer audience, positioning the organization within the professional and academic publishing sector. The available reference material does not establish a complete corporate history, ownership structure, founding date, current executive roster, or comprehensive list of all brands and journals operated by Future Science Group. These details therefore remain unfilled rather than inferred. Future Science Group should be distinguished from unrelated companies using the word “Future” in their names. The authoritative subject for this entry is the publishing group identified by the Wikipedia path Future_Science_Group. The group's public-facing website is its principal reference point, while detailed information about particular imprints, journals, editorial policies, and corporate developments may be distributed across the websites of its publishing units.

Future Science Group is a specialist publisher operating in scientific and medical scholarly communication. Publicly available reference material identifies Future Medicine as a London-based company within the wider Future Science Publishing Group. Future Medicine's principal activity has been the publication of peer-reviewed medical journals, placing the group within the academic and professional publishing industry rather than the consumer-media market. The group's publishing model has included both subscription and open-access formats. Hybrid journals make research available through a combination of subscription access and selected open-access articles, while fully open-access journals make published content available without subscription barriers. For open-access articles, authors, institutions, or funders may be charged article-processing fees. The model reflects the broader shift in scholarly publishing toward multiple access routes and funder-supported dissemination of research. Future Medicine has also promoted an accelerated publication option. Under the described process, accepted articles could be processed and published within roughly six weeks of submission. This service was designed for researchers and medical professionals seeking a faster route to publication, although speed remains dependent on editorial assessment, peer review, revisions, and acceptance. The portfolio associated with Future Medicine has covered specialized clinical and biomedical subjects. The named titles include Clinical Practice, Diabetes Management, Imaging in Medicine, International Journal of Clinical Rheumatology, Interventional Cardiology, and Neuropsychiatry. In 2016, these journals were sold to OMICS Publishing Group and transferred to Pulsus Group, an OMICS-owned company at the time. Reference material characterizes OMICS as widely regarded as a predatory publisher, making the transfer a notable event in the history of the associated publishing portfolio. The available material does not establish whether every title continued under the same editorial or commercial arrangements after the transfer. Beyond the Future Medicine information, the supplied sources do not provide a sufficiently detailed chronology of Future Science Group's founding, ownership, leadership, acquisitions, geographic expansion, or current journal portfolio. Those aspects are consequently left unspecified. The group's current public website remains the main corporate reference supplied for this entry.

• 2016

  Transfer of selected Future Medicine journals

  [1]Future Medicineen.wikipedia.org

  Future Medicine sold several specialist medical journal titles to OMICS Publishing Group. The titles were later moved to Pulsus Group, which OMICS had recently acquired.

A specialist scholarly publisher serving medical, biomedical, and life-sciences research communities through peer-reviewed journal publishing and open-access as well as subscription-based models.

• Medical and biomedical publishing imprint

  Future Medicine

  Future Medicine is a London-based publishing company identified as part of the Future Science Publishing Group. It has focused primarily on peer-reviewed medical journals and has used both hybrid and full open-access publishing models. Its subject coverage has included clinical practice, diabetes, medical imaging, rheumatology, interventional cardiology, and neuropsychiatry. The imprint has also offered an accelerated publication option for accepted articles, with a stated target of publication within approximately six weeks of submission.

• Peer-reviewed journals

  Specialist medical journal portfolio

  The documented Future Medicine portfolio included journals addressing clinical and biomedical specialties. Named examples include Clinical Practice, Diabetes Management, Imaging in Medicine, International Journal of Clinical Rheumatology, Interventional Cardiology, and Neuropsychiatry. These titles were sold in 2016, so their later relationship to Future Science Group is not established by the supplied material.

• 2016

  Sale of selected medical journals to OMICS Publishing GroupM&A

  Background

  Future Medicine's portfolio included several specialist medical journals that were subsequently sold to OMICS Publishing Group.

  Action taken

  The titles Clinical Practice, Diabetes Management, Imaging in Medicine, International Journal of Clinical Rheumatology, Interventional Cardiology, and Neuropsychiatry were transferred to OMICS Publishing Group and moved to Pulsus Group.

  Aftermath

  The transaction changed the ownership and operating context of the named journals. The supplied reference does not provide further verified information about their editorial performance or later disposition.

  Source

1. 1Future Medicineen.wikipedia.org
2. 2Future Science Group official websitefuture-science-group.com